A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis

Phytotherapy Research

Volumn 26, Issue 11, 2012, Pages 1719-1725

  Chandran, Binu ^a   Goel, Ajay ^b  

^a Nirmala Medical Centre Kerala   (India)

^b BAYLOR RESEARCH INSTITUTE   (United States)

Author keywords

American College of Rheumatology criteria; curcumin; diclofenac sodium; Disease Activity Score

Indexed keywords

BCM 95; CURCUMIN; DICLOFENAC; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMERICAN COLLEGE OF RHEUMATOLOGY CRITERIA; ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE 28; DISEASE SEVERITY; DRUG EFFICACY; DRUG FEVER; DRUG RESPONSE; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; EYE SWELLING; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT SWELLING; JOINT TENDERNESS; MALE; MONOTHERAPY; PHARYNGITIS; PILOT STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SIDE EFFECT; SINGLE BLIND PROCEDURE; VISUAL ANALOG SCALE; VISUAL IMPAIRMENT;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CURCUMIN; DICLOFENAC; DRUG THERAPY, COMBINATION; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SINGLE-BLIND METHOD;

EID: 84867891335     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4639     Document Type: Article

References (33)

1. Aggarwal BB, Shishodia S,. 2006. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421.
2. Aggarwal BB, Sundaram C, Malani N, Ichikawa H,. 2007. Curcumin: the Indian solid gold. Adv Exp Med Biol 595: 1-75.
3. Altman RD, Dreiser RL, Fisher CL, Chase WF, Dreher DS, Zacher J,. 2009. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol 36: 1991-1999.
4. Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S,. 2008. A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin. Indian J Pharm Sci 70: 445-449.
5. Bhattacharyya S, Mandal D, Saha B, Sen GS, Das T, Sa G,. 2007. Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction. J Biol Chem 282: 15954-15964.
6. Breedveld F,. 2011. The value of early intervention in RA-a window of opportunity. Clin Rheumatol 30 (Suppl. 1): S33-S39.
7. Breedveld FC, Weisman MH, Kavanaugh AF, et al,. 2006. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54: 26-37.
8. Combe B, Codreanu C, Fiocco U, et al,. 2009. Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study. Ann Rheum Dis 68: 1146-1152.
9. Goel A, Aggarwal BB,. 2010. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 62: 919-930.
10. Goel A, Boland CR, Chauhan DP,. 2001. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 172: 111-118.
11. Goel A, Jhurani S, Aggarwal BB,. 2008a. Multi-targeted therapy by curcumin: how spicy is it? Mol Nutr Food Res 52: 1010-1030.
12. Goel A, Kunnumakkara AB, Aggarwal BB,. 2008b. Curcumin as 'Curecumin': from kitchen to clinic. Biochem Pharmacol 75: 787-809.
13. Kuptniratsaikul V, Thanakhumtorn S, Chinswangwatanakul P, Wattanamongkonsil L, Thamlikitkul V,. 2009. Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis. J Altern Complement Med 15: 891-897.
14. Lipsky PE, van der Heijde DM, St Clair EW, et al,. 2000. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 343: 1594-1602.
15. Maes M, Mihaylova I, Bosmans E,. 2007. Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. Neuro Endocrinol Lett 28: 456-462.
16. Marks WH,. 2011. Tripterygium wilfordii Hook F. versus Sulfasalazine in the treatment of rheumatoid arthritis: a well-designed clinical trial of a botanical demonstrating effectiveness. Fitoterapia 82: 85-87.
17. Mittal N, Joshi R, Hota D, Chakrabarti A,. 2009. Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Phytother Res 23: 507-512.
18. Newsome G,. 2002. Guidelines for the management of rheumatoid arthritis: 2002 update. J Am Acad Nurse Pract 14: 432-437.
19. Rahme E, Bernatsky S,. 2010. NSAIDs and risk of lower gastrointestinal bleeding. Lancet 376: 146-148.
20. Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB,. 2011. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr 6: 93-108.
21. Rindfleisch JA, Muller D,. 2005. Diagnosis and management of rheumatoid arthritis. Am Fam Physician 72: 1037-1047.
22. Ruff CT, Morrow DA, Jarolim P, et al,. 2011. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs. J Rheumatol 38: 1071-1078.
23. Scapagnini G, Sonya V, Nader AG, Calogero C, Zella D, Fabio G,. 2011. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 44: 192-201.
24. Schmajuk G, Trivedi AN, Solomon DH, et al,. 2011. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. J Am Med Assoc 305: 480-486.
25. Shankar S, Srivastava RK,. 2007. Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa. Carcinogenesis 28: 1277-1286.
26. Sharma S, Kulkarni SK, Agrewala JN, Chopra K,. 2006. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol 536: 256-261.
27. Sharma S, Chopra K, Kulkarni SK,. 2007. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res 21: 278-283.
28. Shiozawa S, Tsumiyama K,. 2009. Pathogenesis of rheumatoid arthritis and c-Fos/AP-1. Cell Cycle 8: 1539-1543.
29. Shishodia S, Chaturvedi MM, Aggarwal BB,. 2007. Role of curcumin in cancer therapy. Curr Probl Cancer 31: 243-305.
30. Tajik H, Tamaddonfard E, Hamzeh-Gooshchi N,. 2007. Interaction between curcumin and opioid system in the formalin test of rats. Pak J Biol Sci 10: 2583-2586.
31. Tajik H, Tamaddonfard E, Hamzeh-Gooshchi N,. 2008. The effect of curcumin (active substance of turmeric) on the acetic acid-induced visceral nociception in rats. Pak J Biol Sci 11: 312-314.
32. Van der Heijde D, Klareskog L, Rodriguez-Valverde V, et al,. 2006. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum 54: 1063-1074.
33. Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM,. 2008. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. Clin Ther 30: 1939-1955.